BRCA1 and breast cancer: The report concludes that RRBM reduces the incidence of breast cancer and/or the number of deaths or both.28 Heemskerk-Gerritsen and colleagues concluded from their study that RRBM was associated with lower mortality than surveillance for BRCA1 mutation carriers at the age of 65.